主动脉瓣时空多组学图谱揭示钙化性主动脉瓣疾病的驱动网络
该研究对25例因瓣膜置换手术获取的狭窄主动脉瓣进行转录组学与蛋白质组学分析,结合近红外分子成像和激光捕获显微切割实现疾病阶段与解剖分层特异性采样。研究发现不同疾病阶段及瓣膜微层具有独特分子特征,纤维层来源的瓣膜间质细胞钙化潜能更高,并构建了蛋白质相互作用网络,首次揭示CAVD的分子调控网络。
要点
- 非病变、纤维化及钙化阶段CAVD的转录与蛋白表达特征不同
- 瓣膜微层蛋白质组特征在疾病进展中保持稳定,海绵层GFAP为特异性标志物
- 纤维层瓣膜间质细胞体外钙化潜能高于心室层
核心结论
- 时空分辨多组学与网络系统生物学策略首次识别CAVD的分子调控网络。
研究设计与样本
- 研究分析了25例来自瓣膜置换手术的人狭窄主动脉瓣,采用转录组学及基于串联质量标签的蛋白质组学。
- 通过近红外分子成像引导疾病阶段特异性取样,激光捕获显微切割实现解剖分层特异性。
- 对侧别特异性细胞培养施加多种钙化刺激,评估钙化潜能及基础/刺激后蛋白质组,并构建蛋白质相互作用网络。
主要发现
- 非病变、纤维化及钙化阶段CAVD的全局转录与蛋白表达特征不同。
- 解剖主动脉瓣微层具有独特蛋白质组谱,并在疾病进展中保持;胶质纤维酸性蛋白为海绵层瓣膜间质细胞的特异性标志物。
- CAVD进展以平滑肌细胞活化、炎症及钙化相关通路的出现为标志。
- 纤维层中过表达的蛋白质功能注释于纤维化与钙化通路;体外纤维层来源瓣膜间质细胞钙化潜能高于心室层来源细胞。
- 微层特异性蛋白质组在培养的瓣膜间质细胞中得以保持;碱性和非碱性磷酸酶依赖性钙化刺激下的蛋白质组谱不同,且均与全组织部分重叠。
临床怎么用
- 识别了CAVD不同疾病阶段及瓣膜微层的分子特征,为早期诊断与治疗靶点提供线索。
- 纤维层瓣膜间质细胞钙化潜能更高,提示解剖分层在疾病进展中的重要性。
- 蛋白质相互作用网络与炎症及纤维化疾病接近,提示潜在共用治疗靶点。
- 建立了可广泛适用于心血管疾病综合组学研究的系统疾病本体论新方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No pharmacological therapy exists for calcific aortic valve disease (CAVD), which confers a dismal prognosis without invasive valve replacement. The search for therapeutics and early diagnostics is challenging because CAVD presents in multiple pathological stages. Moreover, it occurs in the context of a complex, multi-layered tissue architecture; a rich and abundant extracellular matrix phenotype; and a unique, highly plastic, and multipotent resident cell population. METHODS: A total of 25 human stenotic aortic valves obtained from valve replacement surgeries were analyzed by multiple modalities, including transcriptomics and global unlabeled and label-based tandem-mass-tagged proteomics. Segmentation of valves into disease stage-specific samples was guided by near-infrared molecular imaging, and anatomic layer-specificity was facilitated by laser capture microdissection. Side-specific cell cultures were subjected to multiple calcifying stimuli, and their calcification potential and basal/stimulated proteomes were evaluated. Molecular (protein-protein) interaction networks were built, and their central proteins and disease associations were identified. RESULTS: Global transcriptional and protein expression signatures differed between the nondiseased, fibrotic, and calcific stages of CAVD. Anatomic aortic valve microlayers exhibited unique proteome profiles that were maintained throughout disease progression and identified glial fibrillary acidic protein as a specific marker of valvular interstitial cells from the spongiosa layer. CAVD disease progression was marked by an emergence of smooth muscle cell activation, inflammation, and calcification-related pathways. Proteins overrepresented in the disease-prone fibrosa are functionally annotated to fibrosis and calcification pathways, and we found that in vitro, fibrosa-derived valvular interstitial cells demonstrated greater calcification potential than those from the ventricularis. These studies confirmed that the microlayer-specific proteome was preserved in cultured valvular interstitial cells, and that valvular interstitial cells exposed to alkaline phosphatase-dependent and alkaline phosphatase-independent calcifying stimuli had distinct proteome profiles, both of which overlapped with that of the whole tissue. Analysis of protein-protein interaction networks found a significant closeness to multiple inflammatory and fibrotic diseases. CONCLUSIONS: A spatially and temporally resolved multi-omics, and network and systems biology strategy identifies the first molecular regulatory networks in CAVD, a cardiac condition without a pharmacological cure, and describes a novel means of systematic disease ontology that is broadly applicable to comprehensive omics studies of cardiovascular diseases.
引用
- Schlotter F, Halu A, Goto S, et al. Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease. Circulation. 2018. PMID: 29588317. doi:10.1161/CIRCULATIONAHA.117.032291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。